For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Ilypsa, Inc.

USPTO Granted Patents = 12

% Expired Patents = 75.0

EPO Patents = 2

Forward Citations = 277

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Dominique Charmot (12 out of 113 patents)

Eric F Connor (9 out of 45 patents)

Han Ting Chang (9 out of 30 patents)

4. Florence Roger (9 out of 10 patents)

5. Jerry M Buysse (4 out of 28 patents)

6. Jun Shao (4 out of 13 patents)

7. Son Hoai Nguyen (4 out of 5 patents)

8. Michael James Cope (4 out of 26 patents)

9. Han-Ting Chang (3 out of 32 patents)

10. Angela Lee (3 out of 6 patents)

11. Deidre Madsen (3 out of 7 patents)

12. Jonathan Mills (3 out of 4 patents)

13. John Fordtran (3 out of 9 patents)

14. Gerrit Klaerner (2 out of 50 patents)

15. Samir Z Zard (2 out of 24 patents)

12 patents: Sort by Forward Citations

1. 8349305 - Crosslinked amine polymers (2013-01-08),

2. 7767768 - Crosslinked amine polymers (2010-08-03),

3. 7754199 - Pharmaceutical compositions comprising crosslinked amine polymer with repeat units derived from polymerization of tertiary amines (2010-07-13),

4. 7718746 - Anion-binding polymers and uses thereof (2010-05-18),

5. 7666898 - Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors (2010-02-23),

6. 7608674 - Pharmaceutical compositions comprising cross-linked small molecule amine polymers (2009-10-27),

7. 7589238 - Treatment of hyperphosphatemia using crosslinked small molecule amine polymers (2009-09-15),

8. 7459502 - Pharmaceutical compositions comprising crosslinked polyamine polymers (2008-12-02),

9. 7449605 - Crosslinked amine polymers (2008-11-11),

10. 7385012 - Polyamine polymers (2008-06-10),

11. 7342083 - Polyamine polymers (2008-03-11),

12. 7335795 - Crosslinked amine polymers (2008-02-26),

Ilypsa, Inc. is a biotechnology company based in Santa Clara, California, specializing in the development of innovative therapies for the treatment of kidney-related disorders. The company focuses on creating novel medical solutions that address unmet clinical needs in renal health. Ilypsa's research is centered on advanced biopharmaceutical technologies, aiming to improve patient outcomes through effective and targeted interventions in the field of nephrology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#253 in Santa Clara, CA

#6,060 in California

#25,540 in US

#48,129 in the World

Santa Clara, CA, United States of America

Ilypsa, Inc.

Forward Citations = 277

21 inventors:

Dominique Charmot (12 out of 113 patents)

Eric F Connor (9 out of 45 patents)

Han Ting Chang (9 out of 30 patents)

4. Florence Roger (9 out of 10 patents)

5. Jerry M Buysse (4 out of 28 patents)

Please report any incorrect information to [email protected]

Loading…